Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer
使用新型药物级植物衍生激动剂 Immunomax® 靶向 TLR-4，作为转移性乳腺癌的治疗策略
期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-014-0322-y
Anahit Ghochikyan, Alexey Pichugin, Alexander Bagaev, Arpine Davtyan, Armine Hovakimyan, Amir Tukhvatulin, Hayk Davtyan, Dmitry Shcheblyakov, Denis Logunov, Marina Chulkina, Anastasia Savilova, Dmitry Trofimov, Edward L Nelson, Michael G Agadjanyan, Ravshan I Ataullakhanov7
